Astrana Health (ASTH) Depreciation & Amortization (CF) (2010 - 2026)

Astrana Health has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $15.5 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $15.5 million, up 126.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.4 million (up 83.22% YoY), and the FY2025 annual result was $45.7 million, up 63.82% from the prior year.
• Depreciation & Amortization (CF) came in at $15.5 million for Q1 2026 at Astrana Health, down from $16.4 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $16.4 million in Q4 2025 to a low of $4.1 million in Q4 2022.
• The 5-year median for Depreciation & Amortization (CF) is $5.1 million (2024), against an average of $7.3 million.
• Across the five-year window, Depreciation & Amortization (CF) slipped 9.46% in 2023 and soared 126.0% in 2026, its largest moves.
• Astrana Health's Depreciation & Amortization (CF) stood at $4.1 million in 2022, then increased by 20.65% to $4.9 million in 2023, then surged by 65.77% to $8.1 million in 2024, then surged by 101.83% to $16.4 million in 2025, then declined by 5.62% to $15.5 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $15.5 million (Q1 2026), $16.4 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.